SI0998276T1 - Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders - Google Patents

Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders

Info

Publication number
SI0998276T1
SI0998276T1 SI9830756T SI9830756T SI0998276T1 SI 0998276 T1 SI0998276 T1 SI 0998276T1 SI 9830756 T SI9830756 T SI 9830756T SI 9830756 T SI9830756 T SI 9830756T SI 0998276 T1 SI0998276 T1 SI 0998276T1
Authority
SI
Slovenia
Prior art keywords
deficit
attention
treatment
carnitine derivatives
hyperactive disorders
Prior art date
Application number
SI9830756T
Other languages
Slovenian (sl)
Inventor
Claudio Cavazza
Original Assignee
Sigma-Tau
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/898,433 external-priority patent/US5869528A/en
Application filed by Sigma-Tau filed Critical Sigma-Tau
Publication of SI0998276T1 publication Critical patent/SI0998276T1/en

Links

SI9830756T 1997-07-22 1998-07-08 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders SI0998276T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/898,433 US5869528A (en) 1997-07-22 1997-07-22 Therapeutical method for the treatment of attention-deficit/hyperactive disorders
EP98932502A EP0998276B1 (en) 1997-07-22 1998-07-08 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
PCT/IT1998/000188 WO1999004785A1 (en) 1997-07-22 1998-07-08 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders

Publications (1)

Publication Number Publication Date
SI0998276T1 true SI0998276T1 (en) 2005-06-30

Family

ID=34751739

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830756T SI0998276T1 (en) 1997-07-22 1998-07-08 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders

Country Status (1)

Country Link
SI (1) SI0998276T1 (en)

Similar Documents

Publication Publication Date Title
HUP0103856A3 (en) Pharmaceutical composition for the treatment of acute disorders
IL135774A0 (en) Use of antinfungal agents for the topical treatment of fungus-induced mucositis
EP1044002A4 (en) Methods for treatment of disorders of cardiac contractility
IL121170A0 (en) Compositions for the treatment of dermatological disorders
EP1063990A4 (en) Therapy of estrogen-associated disorders
PL336290A1 (en) Sulphonamides for treating endothelin-involving disorders
EP0804193A4 (en) Thiazolidine derivatives for the treatment of psoriasis
HUP0001237A3 (en) Methods for treating vascular disorders
IL138093A0 (en) Pharmaceuticals for the imaging of angiogenic disorders
EP0733747A3 (en) Support for shower head
GB9515774D0 (en) Pyrrolo-pyridine derivatives
PL339425A1 (en) Treatment of behavioural disorders
GB9515801D0 (en) Pyrrolo-pyridine derivatives
AU9214498A (en) Treatment of attention-deficit/hyperactivity disorder
PL348107A1 (en) Therapy for improving cognition
IL127496A0 (en) The use of MMP inhibitors for the treatment of ocular angiogenesis
GB9523161D0 (en) Pyrrolo-pyridine derivatives
EP1012150A4 (en) Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
IL132520A0 (en) A pharmaceutical composition for treating skin disorders containing a protein kinase c inhibitor
IL120000A0 (en) Apparatus for cardiac treatment
CZ20011872A3 (en) Isonipecotamides for the treatment of integrin-mediated disorders
IL130831A0 (en) Imino-aza-anthracylinone derivatives for the treatment of amyloidosis
SI0998276T1 (en) Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders
PT1011678E (en) Use of mecamylamine for the treatment of nicotine-responsive neuropsychiatric disorders
HU9603524D0 (en) 1-amino-3-(bicyclic heterocyclic)-6-fluorine-alkyl-uracil derivatives